All News

Collaborations, Mergers & Acquisitions

Autologous vs Allogeneic: What Therapeutic Developers and Manufacturers Really Need to Know
16 March 2023
Autologous vs Allogeneic: What Therapeutic Developers and Manufacturers Really Need to Know
Rupa Pike, Senior Director of
GOSH Enters into Agreement with Leucid Bio at a New Therapy Manufacturing Center
16 March 2023
GOSH Enters into Agreement with Leucid Bio at a New Therapy Manufacturing Center
Leucid Bio, announced an agreement
Pfizer Invests $43 Billion to Acquire Seagen
14 March 2023
Pfizer Invests $43 Billion to Acquire Seagen
Pfizer is to acquire global
Early Adoption and Partnerships – The Secret to Commercialization Success?
2 March 2023
Early Adoption and Partnerships – The Secret to Commercialization Success?
This Briefing from Advanced Therapies
POPULAR NEWS ITEMS
Image
23 March 2023

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image
14 March 2023

Pfizer Invests $43 Billion to Acquire Seagen

Image
2 March 2023

Early Adoption and Partnerships – The Secret to Commercialization Success?

First Gene Therapy for Hemophilia B Approved by the European Commission
24 February 2023
First Gene Therapy for Hemophilia B Approved by the European Commission
UniQure and its global biotechnology
Cell Therapy to Restore Function in Heart Failure Dosed to First Patient, Novo Nordisk and Heartseed Announce
15 February 2023
Cell Therapy to Restore Function in Heart Failure Dosed to First Patient, Novo Nordisk and Heartseed Announce
Heartseed Inc (Tokyo, Japan) and
Increasing Advanced Therapies’ Connectivity and Speed to Market Through Partnership
3 February 2023
Increasing Advanced Therapies’ Connectivity and Speed to Market Through Partnership
Jeff Buck, Vice President, Adherence
Top 10 Events in Cell & Gene Therapy 2022
18 January 2023
Top 10 Events in Cell & Gene Therapy 2022
It’s day 1 of Advanced
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image

Pfizer Invests $43 Billion to Acquire Seagen

Image

Early Adoption and Partnerships – The Secret to Commercialization Success?